InsidersTradesSigma
Track the Diamyd Medical Aktiebolag share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Market capitalisation: €153.4m. The latest transaction was filed on 3 February 2021 (Sale). Among the most active insiders: Anders Essen-Möller. The full history is accessible without an account.
Analysts rate Diamyd Medical Aktiebolag Strong Buy (bullish), based on 1 analysts. Average price target: SEK 1.55.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Diamyd Medical Aktiebolag is a Swedish biopharmaceutical company focused on developing treatments for type 1 diabetes. It is listed on the Stockholm Stock Exchange.